"Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial" by Jose Vazquez

Article

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

BMC Infectious Diseases (2014)

Jose Vazquez, Georgia Regents University
Annette C Reboli, Rowan University
Peter G Pappas, University of Alabama at Birmingham
Thomas F Patterson, University of Texas at Austin
John Reinhardt, Christiana Care Health System
Peter Chin-Hong, University of California, San Francisco
Ellis Tobin, Albany Medical College
Daniel H Kett, University of Miami
Pinaki Biswas, Pfizer
Robert Swanson, Pfizer

Link

Disciplines

Publication Date

January 12, 2014

DOI

10.1186/1471-2334-14-97

Citation Information

Jose Vazquez, Annette C Reboli, Peter G Pappas, Thomas F Patterson, et al.. "Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial" BMC Infectious Diseases Vol. 14 Iss. 1 (2014) p. 97 - 97
Available at: http://works.bepress.com/annette-reboli/11/